COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

• Главные авторы: Z. Ahmadinejad (Автор), R. Assari (Автор), N. Ayoobi Yazdi (Автор), S.-H. Mazloomi (Автор), P. Javanshayani (Автор), H. Khalili Afousi (Автор), V. Ziaee (Автор)
• Формат: ‌
• Опубликовано: PAGEPress Publications, 2020-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

The outbreak of coronavirus disease 2019 (COVID-19) has involved more than 159 countries and more than 5 million people worldwide. A 40-year-old man with a history of rheumatoid arthritis treated with prednisolone, Disease-Modifying Anti-Rheumatic Drugs (DMARDs), and biologic agents was admitted wit...